The Oncology Institute, Inc. (STLN) — Defensive Interval Ratio
The Oncology Institute, Inc. (STLN) has a Defensive Interval Ratio of 255 days as of June 2026. Defensive assets of $66.35 Million (cash $-, short-term investments $-, receivables $66.35 Million) cover 255 days of daily cash needs of $260.11K/day. Explore The Oncology Institute, Inc. long-term investment allocation to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
The Oncology Institute, Inc. Defensive Interval Ratio (2022–2025)
This chart shows how The Oncology Institute, Inc.'s Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 255 days, meaning defensive assets of $66.35 Million can fund 255 days of operations without new revenue. Read The Oncology Institute, Inc. total liabilities for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for The Oncology Institute, Inc. (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for The Oncology Institute, Inc. from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see how large is The Oncology Institute, Inc.'s balance sheet.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 303 days | $59.00 Million | $194.42K/day | $- | $- | ▼ -34 days |
| 2024 | 338 days | $48.34 Million | $143.05K/day | $- | $0.00 | ▼ -625 days |
| 2023 | 962 days | $91.73 Million | $95.31K/day | $- | $49.37 Million | ▼ -261 days |
| 2022 | 1223 days | $99.61 Million | $81.42K/day | $- | $59.80 Million | — |